LifeScience PLUS is pleased to announce that it will be demonstrating BloodSTOP products to international buyers in attendance at the ECRM International Health Care Efficient Program Planning Session in Orlando, FL, December 7-10.
Recent Posts
- LSU Health Study Finds BloodSTOP® iX Trauma Matrix Improves Hemorrhage Control and Survival, Presented at MHSRS 2026
- LifeScience PLUS Secures FDA 510(k) Clearance for BloodSTOP® iX Trauma Matrix for Severe Bleeding Control
- Potential New Application for BloodSTOP® iX in Neurosurgical CSF Leakage Management
- Jacobi Burn Center Highlights Clinical Success with BloodSTOP iX at ABA Annual Meeting
- LifeScience PLUS Announces Publication on Revolutionary eCMC Technology in The Journal of Burn Care and Research